The Food and Drug Administration expanded the approval of weight loss drug Zepbound to treat obstructive sleep apnea in adults with obesity, the drugmaker Eli Lilly said Friday. The decision makes it the first drug treatment for the disorder, which affects about 39 million adults in the United States.



tag:reuters.com,2023:binary_RC26V4AIDH6R-BASEIMAGE

Reuters

United Kingdom

Lilly's weight-loss drug Zepbound wins US FDA approval for sleep apnea


The U.S. Food and Drug Administration on Friday approved Eli Lilly's weight-loss treatment, Zepbound, for obstructive sleep apnea, making it the first drug greenlighted to directly treat patients with the common sleeping disorder.

Ad Fontes Media

All Sides

Media Bias/Fact Check

The Woodbridge Company

The US Food and Drug Administration on Friday approved the first prescription medicine for obstructive sleep apnea: the weight-loss drug Zepbound.

Warner Bros. Discovery

Atlanta

Fulton County

Georgia

United States

FDA approves weight-loss drug Zepbound for obstructive sleep apnea

Aval was granted to tirzepatide, the same substance as Mounjaro used for diabetes and weight loss. The Food and Drug Administration (FDA), the regulatory agency of the United States, approved this Friday the first medication to treat sleep apnea. The endorsement was granted to Zepbound, a version of tirzepatide sold by Eli Lilly in the USA for obesity. The substance is the same as Mounjaro, approved in Brazil for diabetes and used off-label (pur…

Aval foi concedido à tirzepatida, mesma substância do Mounjaro usada para diabetes e perda de peso A Food and Drug Administration  (FDA), agência reguladora dos Estados Unidos, aprovou nesta sexta-feira o primeiro medicamento para tratar a apneia do sono. O aval foi concedido ao Zepbound, versão da tirzepatida vendida pela Eli Lilly nos EUA para obesidade. A substância é a mesma do Mounjaro, aprovado no Brasil para diabetes e usado off-label (fi…

Apneia do sono: EUA aprovam 1º medicamento para tratar a condição

Globo

Roberto Irineu Marinho

Brazil

Sleep apnea: US approves 1st drug to treat the condition

By Meg Tirrell, CNN The U.S. Food and Drug Administration (FDA) approved on Friday the first prescription drug for obstructive sleep apnea: the weight loss drug Zepbound. The drug, which is part of the class known as GLP-1 receptor agonists, which also includes Ozempic, was authorized to treat moderate to severe forms of sleep condition in people with obesity. It should be used along with a low-calorie diet and an increase in physical activity, …

Por Meg Tirrell, CNN La Administración de Alimentos y Medicamentos de EE.UU. (FDA, por sus siglas en inglés) aprobó este viernes el primer medicamento de venta con receta para la apnea obstructiva del sueño: el fármaco para perder peso Zepbound. El medicamento, que forma parte de la clase conocida como agonistas del receptor GLP-1, que también incluye el Ozempic, fue autorizado para tratar formas moderadas a graves de la afección del sueño en pe…

La FDA aprueba el fármaco para la pérdida de peso Zepbound para la apnea obstructiva del sueño

KIFI

News-Press & Gazette Company

Idaho Falls

Bonneville County

Idaho

FDA approves Zepbound weight loss drug for obstructive sleep apnea

By Meg Tirrell, CNN (CNN) — The US Food and Drug Administration on Friday approved the first prescription medicine for obstructive sleep apnea: the weight-loss drug Zepbound. The medicine, part of the class known as GLP-1 receptor agonists that also includes Ozempic, was cleared to treat moderate to severe forms of the sleep condition in people with obesity. It should be used with a reduced-calorie diet and increased physical activity, drugmaker…

KRDO

Colorado Springs

El Paso County

Colorado

The agency's decision expands the use of Zepbound and could potentially pave the way for Eli Lilly to gain broader insurance coverage for the treatment.

CNBC

Roberts family

FDA approves Eli Lilly's weight loss drug Zepbound for sleep apnea, expanding use in U.S.

KVIA

Panama City

Bay County

Florida

The Food and Drug Administration (FDA) approved a weight-loss drug to help sleep apnea, becoming the first drug to treat the disorder affecting millions of Americans.  On Friday, the federal agency green-lighted Eli Lilly’s Zepbound drug for the use, approving a prescription medicine suited for adults suffering from moderate to severe obstructive sleep apnea (OSA)…

The Hill

Nexstar Media Group

Washington

District of Columbia

FDA approves weight-loss drug to treat sleep apnea

Sleep apnea is a condition in which breathing stops intermittently while a person sleeps.

The Straits Times

Singapore Press Holdings

Singapore

US approves Zepbound as first drug treatment for sleep apnea

The Food and Drug Administration on Friday approved Eli Lilly’s anti-obesity drug Zepbound as the first prescription medicine for obstructive sleep apnea, marking a major shift in the treatment of the disorder.  Zepbound, similar to Novo Nordisk’s anti-obesity and diabetes medication Ozempic, was approved to treat obstructive sleep apnea, or OSA, in patients with obesity... The post FDA approves anti-obesity drug as first sleep apnea medication …

Washington Examiner

Philip Anschutz

FDA approves anti-obesity drug as first sleep apnea medication

Obesity

Research

Eli Lilly

Health

Science

Medical

Bloomberg

Star Advertiser

NBC News

Spiegel

Mathrubhumi

Aristegui Noticias

Jovem Pan News

KWWL

Financial Times

القدس العربي

WBAL

Colorado Springs Gazette

KEYT

KESQ

Business Insider (Poland)

KMIZ

KION

Scripps News

Investing.com

BizToc

pantheonsite.io

KPBS

Investor's Business Daily

Your Blog Domain

STAT

SuperHits 103.7 COSY-FM

MedPage Today

NewsX

97.5 Y Country

Newser

98.3 The Coast

News/Talk 94.7 & 970 WMAY

KahawaTungu

Northwest Newsradio

Investing Business Daily

MyCentralOregon.com

Sada El balad

Quality Rock Z94.3

Hola News

Potosinoticias.com

Stockxpo - A professional network of traders, investors and analysts

pipelinereview

Daily Expert News

Sky News: The Latest News from the World

bitlyanews.com

wsjm.com

Daily News Update

Market Screener

Dataemia

Pharmacy Times

thepulseofnh.com

abbonews.com

MyClallamCounty.com

The AI Journal

hcplive.com

Malaysiajournal

noticiasya.com

Busines and Oil News

European Medical Journal

Telemundo Miami (51)

medicaleconomics.com

drugtopics.com

sleepreviewmag.com

contemporarypediatrics.com

FDA Approves Zepbound as First Drug Treatment for Obstructive Sleep Apnea

FDA Approves Zepbound as First Drug Treatment for Obstructive Sleep Apnea

Coverage Details

Give the gift of Perspective

Bias Distribution

Ownership

Similar News Topics

Similar News Topics